Skip Navigation

European Heart Journal 2001 22(8):663-668; doi:10.1053/euhj.2000.2297
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jeron, A
Right arrow Articles by Holmer, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeron, A
Right arrow Articles by Holmer, S
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The D-allele of the ACE polymorphism is related to increased QT dispersion in 609 patients after myocardial infarction

A Jerona,f1, C Hengstenberga, S Engelb, H Löwelb, G.A.J Rieggera, H Schunkerta and S Holmera

a Innere Medizin II, Klinikum der Universität Regensburg, Regensburg, Germany
b GSF Forschungszentrum, Institut für Epidemiologie, Munich-Neuherberg, Germany

revised May 22, 2000; accepted May 24, 2000

Abstract

Aims Prolongation of QT dispersion can be observed in some patients with myocardial infarction and serves as a possible independent risk factor for sudden cardiac death. Angiotensin-converting enzyme (ACE) inhibition has been shown to reduce QT dispersion in myocardial infarction patients. We hypothesized that ACE gene I/D polymorphism, which is known to modulate ACE activity, may also affect QT dispersion after myocardial infarction.

Methods and Results We studied 609 myocardial infarction patients (532 men, aged 56·1±0·3; mean 5·5 years after myocardial infarction) from a population-based myocardial infarction register by standardized questionnaire, anthropometry, ECG, echocardiography, and genotyping of ACE I/D polymorphism. In addition, 540 unaffected siblings (251 men, age 54·6±0·4 years) of these patients were studied by the same protocol. As compared with their healthy siblings, mean QT dispersion was prolonged in myocardial infarction patients (65·9±1·4ms vs 91·2±2·3ms, respectively, P<0·001). QT dispersion was negatively correlated to left ventricular ejection fraction (P<0·005). The ACE DD-genotype was associated with longer QT dispersion in myocardial infarction patients (103·0±4·6ms vs 81·9±4·5ms in the II group, P<0·001). This association was noted to be strong in multivariate analyses that included age, gender, ejection fraction, left ventricular end-diastolic diameter, medication, and heart rate. In contrast, no association between the ACE DD-genotype and QT dispersion was detected in healthy siblings of myocardial infarction patients.

Conclusion Thus, the ACE D-allele may be associated with increased QT dispersion in patients after myocardial infarction but not in healthy subjects. An interaction of myocardial damage and genetic predisposition that both enhance the activity of the renin angiotensin system may decrease the repolarization homogeneity of the heart.

Key Words: ACE polymorphism, renin angiotensin system, myocardial infarction, QT dispersion, remodelling

f1 Correspondence: Andreas Jeron, MD, Innere Medizin II, Klinikum der Universität Regensburg, Franz-Josef-Strauss-Allee 11, 93042 Regensburg, Germany.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
G. Montalescot, M. Cohen, G. Salette, W. J. Desmet, C. Macaya, P. E.G. Aylward, Ph. G. Steg, H. D. White, R. Gallo, S. R. Steinhubl, et al.
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial
Eur. Heart J., February 2, 2008; 29(4): 462 - 471.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
R. Due-Andersen, T. Hoi-Hansen, N. V. Olsen, C. E. Larroude, J. K. Kanters, F. Boomsma, U. Pedersen-Bjergaard, and B. Thorsteinsson
Cardiac repolarization during hypoglycaemia and hypoxaemia in healthy males: impact of renin-angiotensin system activity
Europace, February 1, 2008; 10(2): 219 - 226.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
G. Montalescot, H. D. White, R. Gallo, M. Cohen, P. G. Steg, P. E.G. Aylward, C. Bode, M. Chiariello, S. B. King III, R. A. Harrington, et al.
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
N. Engl. J. Med., September 7, 2006; 355(10): 1006 - 1017.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Kaab and E. Schulze-Bahr
Susceptibility genes and modifiers for cardiac arrhythmias
Cardiovasc Res, August 15, 2005; 67(3): 397 - 413.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
M. Firouzi and W. A. Groenewegen
Gene polymorphisms and cardiac arrhythmias
Europace, January 1, 2003; 5(3): 235 - 242.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
D.R. Woods, D. Brull, and H. Montgomery
Increased QT dispersion with the D-allele of the ACE polymorphism
Eur. Heart J., April 2, 2001; 22(8): 618 - 621.
[PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.